APAC Liver Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific liver cancer diagnostics market is projected to register a substantial CAGR of 7.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Liver Cancer Diagnostics Market, By Test Type (Imaging, Biopsy, Genomic Test, and Others), Cancer Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Primary Liver Cancer and Secondary Liver Cancer), Product (Platform-Based Products, Instrument Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application (Screening, Diagnostic and Predictive, Prognostic, and Research), Gender (Female and Male), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and the rest of Asia-Pacific ) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of Asia-Pacific liver cancer diagnostics market are:

Increasing early diagnosis of liver cancer

Rise in awareness about the liver cancer diagnostics

Market Players:

Some of the major players operating in the Asia-Pacific liver cancer diagnostics market are:

F. Hoffmann-La Roche Ltd.

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Agilent Technologies, Inc.

Illumina, Inc.

QIAGEN

FUJIFILM Corporation

Sysmex Corporation AB

Scitex Pte Ltd. (Subsidiary of Danaher.)

Epigenomics AG

Tebubio

Fujirebio

Diagnostic Biosystems Inc.

Q-LINE BIOTECH PVT LTD.

MOLGEN

BIOCEPT, INC.

Boditech Med Inc.

Elabscience Biotechnology Inc.

Hipro Biotechnology Co., Ltd.

Altogen Biosystems

Tosoh India Pvt. Ltd.

ABK Biomedical Inc.

Diazyme Laboratories, Inc.

1 INTRODUCTION 55

1.1 OBJECTIVES OF THE STUDY 55
1.2 MARKET DEFINITION 55
1.3 OVERVIEW OF THE ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET 55
1.4 CURRENCY AND PRICING 57
1.5 LIMITATIONS 57
1.6 MARKETS COVERED 58

2 MARKET SEGMENTATION 61

2.1 MARKETS COVERED 61
2.2 GEOGRAPHICAL SCOPE 62
2.3 YEARS CONSIDERED FOR THE STUDY 63
2.4 DBMR TRIPOD DATA VALIDATION MODEL 64
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 67
2.6 MULTIVARIATE MODELLING 68
2.7 MARKET APPLICATION COVERAGE GRID 69
2.8 TEST TYPE LIFELINE CURVE 70
2.9 DBMR MARKET POSITION GRID 71
2.10 VENDOR SHARE ANALYSIS 72
2.11 SECONDARY SOURCES 73
2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

4 PREMIUM INSIGHTS 77

4.1 PESTLE ANALYSIS 78
4.2 PORTER ANALYSIS 79
4.3 EPIDEMIOLOGY 80

5 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, REGULATIONS 81

6 INDUSTRY INSIGHTS 85

7 MARKET OVERVIEW 87

7.1 DRIVERS 89
- 7.1.1 UNMET NEED FOR NON-INVASIVE, ACCURATE, AND RELIABLE DIAGNOSTIC TESTS FOR EARLIER CANCER DETECTION 89
- 7.1.2 INCREASING EARLY DIAGNOSIS OF LIVER CANCER 90
- 7.1.3 INCREASING CASES OF LIVER CANCER 92
- 7.1.4 RISE IN DIAGNOSTIC PRODUCT APPROVALS 93
7.2 RESTRAINTS 95
- 7.2.1 BARRIERS TO LIVER CANCER DIAGNOSIS AND POOR PROGNOSIS 95
- 7.2.2 HIGH FALSE-POSITIVES AND POOR SENSITIVITY OF LIVER CANCER DIAGNOSIS 96
7.3 OPPORTUNITIES 96
- 7.3.1 INCREASING AWARENESS TOWARDS LIVER CANCER 96
- 7.3.2 GOVERNMENT INITIATIVES TOWARD LIVER CANCER DIAGNOSTICS 96
- 7.3.3 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE 97
7.4 CHALLENGES 98
- 7.4.1 STRICT REGULATIONS FOR THE APPROVAL OF LIVER CANCER DIAGNOSTIC PRODUCTS 98
- 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 99

8 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 100

8.1 OVERVIEW 101
8.2 IMAGING TEST 104
- 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 105
  - 8.2.1.1 MR ANGIOGRAPHY (MRA) 105
  - 8.2.1.2 MR CHOLANGIOPANCREATOGRAPHY 106
- 8.2.2 COMPUTED TOMOGRAPHY 106
- 8.2.3 POSITRON EMISSION TOMOGRAPHY 106
- 8.2.4 ULTRASOUND 106
- 8.2.5 OTHERS 106
8.3 GENOMIC TEST 106
8.4 BIOPSY 107
- 8.4.1 FINE NEEDLE ASPIRATION BIOPSY 108
- 8.4.2 CORE NEEDLE BIOPSY 108
- 8.4.3 LAPAROSCOPY 108
8.5 OTHERS 109

9 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGE 110

9.1 OVERVIEW 111
9.2 STAGE III 114
9.3 STAGE II 115
9.4 STAGE IV 116
9.5 STAGE I 117
9.6 STAGE 0 118

10 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 119

10.1 OVERVIEW 120
10.2 SECONDARY LIVER CANCER 123
- 10.2.1 HEMANGIOMA 124
- 10.2.2 HEPATIC ADENOMA 124
- 10.2.3 FOCAL NODULAR HYPERPLASIA 124
10.3 PRIMARY LIVER CANCER 124
- 10.3.1 HEPATOCELLULAR CARCINOMA (HCC) 125
- 10.3.2 INTRAHEPATIC CHOLANGIOCARCINOMA (BILE DUCT CANCER) 125
- 10.3.3 ANGIOSARCOMA HEMANGIOSARCOMA 126
- 10.3.4 HEPATOBLASTOMA 126

11 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT 127

11.1 OVERVIEW 128
11.2 PLATFORM BASED PRODUCTS 131
- 11.2.1 NEXT GENERATION SEQUENCING 132
- 11.2.2 MICROARRAYS 132
- 11.2.3 PCR 132
- 11.2.4 OTHERS 132
11.3 INSTRUMENT BASED PRODUCTS 132
- 11.3.1 IMAGING 133
- 11.3.2 BIOPSY 133
11.4 KITS AND REAGENTS 134
- 11.4.1 ELISA TEST KITS 135
- 11.4.2 CASSETTE TEST KITS 135
- 11.4.3 OTHERS 135
11.5 OTHER CONSUMABLES 135

12 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION 136

12.1 OVERVIEW 137
12.2 SCREENING 140
- 12.2.1 PLATFORM BASED PRODUCTS 141
- 12.2.2 INSTRUMENT BASED PRODUCTS 141
- 12.2.3 KITS AND REAGENTS 141
- 12.2.4 OTHER CONSUMABLES 141
12.3 DIAGNOSTIC AND PREDICTIVE 141
- 12.3.1 PLATFORM BASED PRODUCTS 142
- 12.3.2 INSTRUMENT BASED PRODUCTS 142
- 12.3.3 KITS AND REAGENTS 142
- 12.3.4 OTHER CONSUMABLES 143
12.4 PROGNOSTIC 143
- 12.4.1 PLATFORM BASED PRODUCTS 144
- 12.4.2 INSTRUMENT BASED PRODUCTS 144
- 12.4.3 KITS AND REAGENTS 144
- 12.4.4 OTHER CONSUMABLES 144
12.5 RESEARCH 144
- 12.5.1 PLATFORM BASED PRODUCTS 146
- 12.5.2 INSTRUMENT BASED PRODUCTS 146
- 12.5.3 KITS AND REAGENTS 146
- 12.5.4 OTHER CONSUMABLES 146

13 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY 147

13.1 OVERVIEW 148
13.2 FLUORESCENT IN SITU HYBRIDIZATION 151
13.3 NEXT GENERATION SEQUENCING 152
13.4 FLUORIMMUNOASSAY 153
13.5 COMPARATIVE GENOMIC HYBRIDIZATION 154
13.6 IMMUNOHISTOCHEMICAL 155
13.7 OTHERS 156

14 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY GENDER 157

14.1 OVERVIEW 158
14.2 MALE 161
14.3 FEMALE 162

15 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY END USER 163

15.1 OVERVIEW 164
15.2 HOSPITALS 167
15.3 DIAGNOSTIC CENTERS 168
15.4 CANCER RESEARCH CENTERS 169
15.5 AMBULATORY SURGICAL CENTERS 170
15.6 ACADEMIC INSTITUTES 171
15.7 OTHERS 172

16 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 173

16.1 OVERVIEW 174
16.2 DIRECT TENDER 177
16.3 RETAIL SALES 178
16.4 OTHERS 179

17 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY REGION 180

17.1 ASIA-PACIFIC 181
- 17.1.1 CHINA 192
- 17.1.2 INDIA 198
- 17.1.3 JAPAN 204
- 17.1.4 INDONESIA 210
- 17.1.5 PHILIPPINES 216
- 17.1.6 THAILAND 222
- 17.1.7 AUSTRALIA 228
- 17.1.8 MALAYSIA 234
- 17.1.9 SOUTH KOREA 240
- 17.1.10 SINGAPORE 246
- 17.1.11 VIETNAM 252
- 17.1.12 REST OF ASIA-PACIFIC 258

18 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 259

18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 259

19 SWOT ANALYSIS 260

20 COMPANY PROFILE 261

20.1 F. HOFFMANN-LA ROCHE LTD. 261
- 20.1.1 COMPANY SNAPSHOT 261
- 20.1.2 REVENUE ANALYSIS 261
- 20.1.3 COMPANY SHARE ANALYSIS 262
- 20.1.4 PRODUCT PORTFOLIO 262
- 20.1.5 RECENT DEVELOPMENT 262
20.2 KONINLIJKE PHILIPS N.V. 263
- 20.2.1 COMPANY SNAPSHOT 263
- 20.2.2 REVENUE ANALYSIS 263
- 20.2.3 COMPANY SHARE ANALYSIS 264
- 20.2.4 PRODUCT PORTFOLIO 264
- 20.2.5 RECENT DEVELOPMENT 264
20.3 THERMO FISHER SCIENTIFIC INC. 265
- 20.3.1 COMPANY SNAPSHOT 265
- 20.3.2 REVENUE ANALYSIS 265
- 20.3.3 COMPANY SHARE ANALYSIS 266
- 20.3.4 PRODUCT PORTFOLIO 266
- 20.3.5 RECENT DEVELOPMENT 266
20.4 BD 267
- 20.4.1 COMPANY SNAPSHOT 267
- 20.4.2 REVENUE ANALYSIS 267
- 20.4.3 COMPANY SHARE ANALYSIS 268
- 20.4.4 PRODUCT PORTFOLIO 268
- 20.4.5 RECENT DEVELOPMENTS 269
20.5 SIEMENS HEALTHCARE GMBH 270
- 20.5.1 COMPANY SNAPSHOT 270
- 20.5.2 REVENUE ANALYSIS 270
- 20.5.3 COMPANY SHARE ANALYSIS 271
- 20.5.4 PRODUCT PORTFOLIO 271
- 20.5.5 RECENT DEVELOPMENT 271
20.6 AGILENT TECHNOLOGIES, INC. 272
- 20.6.1 COMPANY SNAPSHOT 272
- 20.6.2 REVENUE ANALYSIS 272
- 20.6.3 PRODUCT PORTFOLIO 273
- 20.6.4 RECENT DEVELOPMENTS 273
20.7 ABK BIOMEDICAL INC. 274
- 20.7.1 COMPANY SNAPSHOT 274
- 20.7.2 PRODUCT PORTFOLIO 274
- 20.7.3 RECENT DEVELOPMENT 274
20.8 AB SCIEX PTE LTD. (SUBSIDIARY OF DANAHER.) 275
- 20.8.1 COMPANY SNAPSHOT 275
- 20.8.2 REVENUE ANALYSIS 275
- 20.8.3 PRODUCT PORTFOLIO 276
- 20.8.4 RECENT DEVELOPMENT 276
20.9 ALTOGEN BIOSYSTEMS 277
- 20.9.1 COMPANY SNAPSHOT 277
- 20.9.2 PRODUCT PORTFOLIO 277
- 20.9.3 RECENT DEVELOPMENT 277
20.10 BIOCEPT, INC. 278
- 20.10.1 COMPANY SNAPSHOT 278
- 20.10.2 REVENUE ANALYSIS 278
- 20.10.3 PRODUCT PORTFOLIO 279
- 20.10.4 RECENT DEVELOPMENT 279
20.11 BODITECH MED INC. 280
- 20.11.1 COMPANY SNAPSHOT 280
- 20.11.2 PRODUCT PORTFOLIO 280
- 20.11.3 RECENT DEVELOPMENTS 280
20.12 DIAGNOSTIC BIOSYSTEMS INC. 281
- 20.12.1 COMPANY SNAPSHOT 281
- 20.12.2 PRODUCT PORTFOLIO 281
- 20.12.3 RECENT DEVELOPMENT 281
20.13 DIAZYME LABORATORIES, INC. 282
- 20.13.1 COMPANY SNAPSHOT 282
- 20.13.2 PRODUCT PORTFOLIO 282
- 20.13.3 RECENT DEVELOPMENT 282
20.14 ELABSCIENCE BIOTECHNOLOGY INC. 283
- 20.14.1 COMPANY SNAPSHOT 283
- 20.14.2 PRODUCT PORTFOLIO 283
- 20.14.3 RECENT DEVELOPMENT 283
20.15 EPIGENOMICS AG 284
- 20.15.1 COMPANY SNAPSHOT 284
- 20.15.2 REVENUE ANALYSIS 284
- 20.15.3 PRODUCT PORTFOLIO 285
- 20.15.4 RECENT DEVELOPMENT 285
20.16 FUJIFILM CORPORATION 286
- 20.16.1 COMPANY SNAPSHOT 286
- 20.16.2 REVENUE ANALYSIS 286
- 20.16.3 PRODUCT PORTFOLIO 287
- 20.16.4 RECENT DEVELOPMENT 287
20.17 FUJIREBIO 288
- 20.17.1 COMPANY SNAPSHOT 288
- 20.17.2 PRODUCT PORTFOLIO 288
- 20.17.3 RECENT DEVELOPMENTS 288
20.18 HIPRO BIOTECHNOLOGY CO., LTD. 289
- 20.18.1 COMPANY SNAPSHOT 289
- 20.18.2 PRODUCT PORTFOLIO 289
- 20.18.3 RECENT DEVELOPMENT 289
20.19 ILLUMINA, INC. 290
- 20.19.1 COMPANY SNAPSHOT 290
- 20.19.2 REVENUE ANALYSIS 290
- 20.19.3 PRODUCT PORTFOLIO 291
- 20.19.4 RECENT DEVELOPMENTS 292
20.20 MOLGEN 293
- 20.20.1 COMPANY SNAPSHOT 293
- 20.20.2 PRODUCT PORTFOLIO 293
- 20.20.3 RECENT DEVELOPMENT 293

20.21 QIAGEN 294
- 20.21.1 COMPANY SNAPSHOT 294
- 20.21.2 REVENUE ANALYSIS 294
- 20.21.3 PRODUCT PORTFOLIO 295
- 20.21.4 RECENT DEVELOPMENT 295
20.22 Q-LINE BIOTECH PVT LTD. 296
- 20.22.1 COMPANY SNAPSHOT 296
- 20.22.2 PRODUCT PORTFOLIO 296
- 20.22.3 RECENT DEVELOPMENT 296
20.23 SYSMEX CORPORATION 297
- 20.23.1 COMPANY SNAPSHOT 297
- 20.23.2 REVENUE ANALYSIS 297
- 20.23.3 PRODUCT PORTFOLIO 298
- 20.23.4 RECENT DEVELOPMENT 298
20.24 TEBUBIO 299
- 20.24.1 COMPANY SNAPSHOT 299
- 20.24.2 PRODUCT PORTFOLIO 299
- 20.24.3 RECENT DEVELOPMENT 299
20.25 TOSOH INDIA PVT. LTD. 300
- 20.25.1 COMPANY SNAPSHOT 300
- 20.25.2 PRODUCT PORTFOLIO 300
- 20.25.3 RECENT DEVELOPMENT 300

21 QUESTIONNAIRE 301

22 RELATED REPORTS 305

LIST OF TABLES

TABLE 1 DIFFERENT TYPES OF CANCER NON-INVASIVE SCREENING TESTS FOR DIFFERENT TYPES OF CANCERS 66
TABLE 2 LIVER CANCER RATES 69
TABLE 3 APPROVED DIAGNOSTICS OF LIVER CANCER 70
TABLE 4 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 5 ASIA PACIFIC IMAGING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 6 ASIA PACIFIC IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 81
TABLE 7 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 81
TABLE 8 ASIA PACIFIC GENETIC TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 9 ASIA PACIFIC BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 10 ASIA PACIFIC BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 84
TABLE 11 ASIA PACIFIC OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 12 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 89
TABLE 13 ASIA PACIFIC STAGE III IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 14 ASIA PACIFIC STAGE II IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
TABLE 15 ASIA PACIFIC STAGE IV IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 16 ASIA PACIFIC STAGE I IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 17 ASIA PACIFIC STAGE 0 IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 18 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 98
TABLE 19 ASIA PACIFIC SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
TABLE 20 ASIA PACIFIC RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 100
TABLE 21 ASIA PACIFIC CLEAR CELL RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 22 ASIA PACIFIC CLEAR CELL RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 101
TABLE 23 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 106
TABLE 24 ASIA PACIFIC PLATFORM BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 25 ASIA PACIFIC PLATFORM BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 26 ASIA PACIFIC INSTRUMENT BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 27 ASIA PACIFIC INSTRUMENT BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 28 ASIA PACIFIC KITS AND REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
TABLE 29 ASIA PACIFIC KITS AND REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 110
TABLE 30 ASIA PACIFIC OTHER CONSUMABLES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 31 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 32 ASIA PACIFIC SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 33 ASIA PACIFIC SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 116
TABLE 34 ASIA PACIFIC DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 118
TABLE 35 ASIA PACIFIC DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 118
TABLE 36 ASIA PACIFIC PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 119
TABLE 37 ASIA PACIFIC PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 38 ASIA PACIFIC RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 39 ASIA PACIFIC RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 121
TABLE 40 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 126
TABLE 41 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 127
TABLE 42 ASIA PACIFIC NEXT GENERATION SEQUENCING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 128
TABLE 43 ASIA PACIFIC FLUORIMMUNOASSAY IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 129
TABLE 44 ASIA PACIFIC COMPARATIVE GENOMIC HYBRIDIZATION IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 45 ASIA PACIFIC IMMUNOHISTOCHEMICAL IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
TABLE 46 ASIA PACIFIC OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
TABLE 47 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 136
TABLE 48 ASIA PACIFIC MALE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 137
TABLE 49 ASIA PACIFIC FEMALE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 138
TABLE 50 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 142
TABLE 51 ASIA PACIFIC HOSPITALS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 143
TABLE 52 ASIA PACIFIC DIAGNOSTIC CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 144
TABLE 53 ASIA PACIFIC CANCER RESEARCH CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 145
TABLE 54 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 146
TABLE 55 ASIA PACIFIC ACADEMIC INSTITUTES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
TABLE 56 ASIA PACIFIC OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 148
TABLE 57 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 152
TABLE 58 ASIA PACIFIC DIRECT TENDER IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 153
TABLE 59 ASIA PACIFIC RETAIL SALES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 154
TABLE 60 ASIA PACIFIC OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 155
TABLE 61 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 162
TABLE 62 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 63 ASIA-PACIFIC IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 64 ASIA-PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 163
TABLE 65 ASIA-PACIFIC BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 163
TABLE 66 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 163
TABLE 67 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 163
TABLE 68 ASIA-PACIFIC SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 164
TABLE 69 ASIA-PACIFIC PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 164
TABLE 70 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 71 ASIA-PACIFIC PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 72 ASIA-PACIFIC INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 73 ASIA-PACIFIC KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 74 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 165
TABLE 75 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 76 ASIA-PACIFIC SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 77 ASIA-PACIFIC DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 78 ASIA-PACIFIC PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 79 ASIA-PACIFIC RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 167
TABLE 80 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 167
TABLE 81 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 167
TABLE 82 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 167
TABLE 83 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 84 CHINA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 85 CHINA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 168
TABLE 86 CHINA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 87 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 169
TABLE 88 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
TABLE 89 CHINA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
TABLE 90 CHINA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
TABLE 91 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 92 CHINA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 93 CHINA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 94 CHINA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 95 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 171
TABLE 96 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
TABLE 97 CHINA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
TABLE 98 CHINA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
TABLE 99 CHINA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
TABLE 100 CHINA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
TABLE 101 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 172
TABLE 102 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 172
TABLE 103 CHINA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 173
TABLE 104 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
TABLE 105 INDIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
TABLE 106 INDIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 174
TABLE 107 INDIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 175
TABLE 108 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 175
TABLE 109 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
TABLE 110 INDIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
TABLE 111 INDIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 176
TABLE 112 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 113 INDIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 114 INDIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 115 INDIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
TABLE 116 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 177
TABLE 117 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 118 INDIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 119 INDIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
TABLE 120 INDIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
TABLE 121 INDIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
TABLE 122 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 178
TABLE 123 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 179
TABLE 124 INDIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 179
TABLE 125 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 126 JAPAN IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 127 JAPAN MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 180
TABLE 128 JAPAN BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
TABLE 129 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 181
TABLE 130 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
TABLE 131 JAPAN SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
TABLE 132 JAPAN PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 182
TABLE 133 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
TABLE 134 JAPAN PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
TABLE 135 JAPAN INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
TABLE 136 JAPAN KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 183
TABLE 137 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 183
TABLE 138 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
TABLE 139 JAPAN SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
TABLE 140 JAPAN DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 141 JAPAN PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 142 JAPAN RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 143 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 184
TABLE 144 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 185
TABLE 145 JAPAN LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 185
TABLE 146 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 186
TABLE 147 INDONESIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 186
TABLE 148 INDONESIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 186
TABLE 149 INDONESIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 187
TABLE 150 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 187
TABLE 151 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 187
TABLE 152 INDONESIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 187
TABLE 153 INDONESIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 188
TABLE 154 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 188
TABLE 155 INDONESIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 188
TABLE 156 INDONESIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 188
TABLE 157 INDONESIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 189
TABLE 158 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 189
TABLE 159 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
TABLE 160 INDONESIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 190
TABLE 161 INDONESIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 190
TABLE 162 INDONESIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 190
TABLE 163 INDONESIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 190
TABLE 164 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 191
TABLE 165 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 191
TABLE 166 INDONESIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 191
TABLE 167 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 192
TABLE 168 PHILIPPINES IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 192
TABLE 169 PHILIPPINES MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 192
TABLE 170 PHILIPPINES BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 193
TABLE 171 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 193
TABLE 172 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 193
TABLE 173 PHILIPPINES SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 193
TABLE 174 PHILIPPINES PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 194
TABLE 175 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 194
TABLE 176 PHILIPPINES PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 194
TABLE 177 PHILIPPINES INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 194
TABLE 178 PHILIPPINES KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 195
TABLE 179 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 195
TABLE 180 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
TABLE 181 PHILIPPINES SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
TABLE 182 PHILIPPINES DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
TABLE 183 PHILIPPINES PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
TABLE 184 PHILIPPINES RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 196
TABLE 185 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 197
TABLE 186 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 197
TABLE 187 PHILIPPINES LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 197
TABLE 188 THAILAND LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 198

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION 36
FIGURE 2 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 39
FIGURE 3 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 40
FIGURE 4 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 41
FIGURE 5 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 41
FIGURE 6 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 42
FIGURE 7 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID 44
FIGURE 8 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 46
FIGURE 9 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 47
FIGURE 10 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION 51
FIGURE 11 GROWING AWARENESS OF LIVER CANCER AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET FROM 2023 TO 2030 52
FIGURE 12 THE IMAGING TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET IN 2023 & 2030 52
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET 63
FIGURE 14 THE ASIA PACIFIC MORTALITY RATE DUE TO CANCER 66
FIGURE 15 INCREASING ASIA PACIFIC CANCER RATE IN 2020 67
FIGURE 16 BARRIERS TO EARLY CANCER DIAGNOSIS AND TREATMENT 70
FIGURE 17 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 76
FIGURE 18 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 77
FIGURE 19 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 77
FIGURE 20 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 78
FIGURE 21 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2022 86
FIGURE 22 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2023-2030 (USD MILLION) 87
FIGURE 23 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, CAGR (2023-2030) 87
FIGURE 24 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, LIFELINE CURVE 88
FIGURE 25 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 95
FIGURE 26 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 96
FIGURE 27 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 96
FIGURE 28 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 97
FIGURE 29 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2022 103
FIGURE 30 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2023-2030 (USD MILLION) 104
FIGURE 31 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, CAGR (2023-2030) 104
FIGURE 32 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, LIFELINE CURVE 105
FIGURE 33 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2022 112
FIGURE 34 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 113
FIGURE 35 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2023-2030) 113
FIGURE 36 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 114
FIGURE 37 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2022 123
FIGURE 38 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 124
FIGURE 39 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, CAGR (2023-2030) 124
FIGURE 40 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, LIFELINE CURVE 125
FIGURE 41 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2022 133
FIGURE 42 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2023-2030 (USD MILLION) 134
FIGURE 43 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, CAGR (2023-2030) 134
FIGURE 44 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, LIFELINE CURVE 135
FIGURE 45 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2022 139
FIGURE 46 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 140
FIGURE 47 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 140
FIGURE 48 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 141
FIGURE 49 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 149
FIGURE 50 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 150
FIGURE 51 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 150
FIGURE 52 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 151
FIGURE 53 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 157
FIGURE 54 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 159
FIGURE 55 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 159
FIGURE 56 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 160
FIGURE 57 ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030) 160
FIGURE 58 ASIA PACIFIC LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 234